AngustineCAS# 40041-96-1 |
Quality Control & MSDS
Number of papers citing our products
Chemical structure
3D structure
Cas No. | 40041-96-1 | SDF | Download SDF |
PubChem ID | 441983 | Appearance | Yellow powder |
Formula | C20H15N3O | M.Wt | 313.4 |
Type of Compound | Alkaloids | Storage | Desiccate at -20°C |
Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
Chemical Name | 19-ethenyl-3,13,17-triazapentacyclo[11.8.0.02,10.04,9.015,20]henicosa-1(21),2(10),4,6,8,15(20),16,18-octaen-14-one | ||
SMILES | C=CC1=CN=CC2=C1C=C3C4=C(CCN3C2=O)C5=CC=CC=C5N4 | ||
Standard InChIKey | FACXQEOSOVJIPD-UHFFFAOYSA-N | ||
Standard InChI | InChI=1S/C20H15N3O/c1-2-12-10-21-11-16-15(12)9-18-19-14(7-8-23(18)20(16)24)13-5-3-4-6-17(13)22-19/h2-6,9-11,22H,1,7-8H2 | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
Angustine Dilution Calculator
Angustine Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 3.1908 mL | 15.9541 mL | 31.9081 mL | 63.8162 mL | 79.7703 mL |
5 mM | 0.6382 mL | 3.1908 mL | 6.3816 mL | 12.7632 mL | 15.9541 mL |
10 mM | 0.3191 mL | 1.5954 mL | 3.1908 mL | 6.3816 mL | 7.977 mL |
50 mM | 0.0638 mL | 0.3191 mL | 0.6382 mL | 1.2763 mL | 1.5954 mL |
100 mM | 0.0319 mL | 0.1595 mL | 0.3191 mL | 0.6382 mL | 0.7977 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- Caloxanthone B
Catalog No.:BCN9444
CAS No.:155233-17-3
- Stipuleanoside R1
Catalog No.:BCN9443
CAS No.:96627-79-1
- Adenostemmoic acid C
Catalog No.:BCN9442
CAS No.:130217-18-4
- Withaphysalin C
Catalog No.:BCN9441
CAS No.:57485-60-6
- ent-Toddalolactone
Catalog No.:BCN9440
CAS No.:1570054-19-1
- 1-Oxohederagenin
Catalog No.:BCN9439
CAS No.:618390-67-3
- 1,5-Epoxy-3-hydroxy-1-(3,4-dihydroxy-5-methoxyphenyl)-7-(4-hydroxy-3-methoxyphenyl)heptane
Catalog No.:BCN9438
CAS No.:182227-93-6
- Cucurbitacin IIa 2-O-glucoside
Catalog No.:BCN9437
CAS No.:77704-34-8
- [4]-Gingerdiol
Catalog No.:BCN9436
CAS No.:53254-75-4
- Physaminimin N
Catalog No.:BCN9435
CAS No.:2131235-87-3
- Orthosiphol B
Catalog No.:BCN9434
CAS No.:144078-08-0
- Neoorthosiphol A
Catalog No.:BCN9433
CAS No.:243448-72-8
- Uncarine F
Catalog No.:BCN9446
CAS No.:14019-66-0
- ent-15α-Acetoxy-11α-hydroxykaur-16-en-19-oic acid
Catalog No.:BCN9447
CAS No.:70324-38-8
- (-)-Toddalolactone 3′-O-β-D-glucopyranoside
Catalog No.:BCN9448
CAS No.:1176645-57-0
- 12-O-Methylinophyllum A
Catalog No.:BCN9449
CAS No.:2131757-10-1
- Seselin
Catalog No.:BCN9450
CAS No.:523-59-1
- 5-Methoxyseselin
Catalog No.:BCN9451
CAS No.:31525-76-5
- 3,6-Dihydroxy-1,2,7-trimethoxyxanthone
Catalog No.:BCN9452
CAS No.:916210-79-2
- Trigochinin A
Catalog No.:BCN9453
CAS No.:1210299-29-8
- Isozedoarondiol
Catalog No.:BCN9454
CAS No.:108887-68-9
- 1,8-Dihydroxy-p-menth-3-en-2-one
Catalog No.:BCN9455
CAS No.:1392224-56-4
- Toddalolactone 3′-O-ethyl ether
Catalog No.:BCN9456
CAS No.:1538607-30-5
- Schisandrolic acid
Catalog No.:BCN9457
CAS No.:55511-17-6
Natural indole butyrylcholinesterase inhibitors from Nauclea officinalis.[Pubmed:25636869]
Phytomedicine. 2015 Jan 15;22(1):45-8.
Nine monoterpenoid indole alkaloids; naucletine (1), angustidine (2), nauclefine (3), Angustine (4), naucline (5), angustoline (6), harmane (7), 3,14-dihydroangustoline (8), strictosamide (9) and one quinoline alkaloid glycoside; pumiloside (10) from Nauclea officinalis were tested for cholinesterase inhibitory activity. All the alkaloids except for pumiloside (10) showed strong to weak BChE inhibitory effect with IC50 values ranging between 1.02-168.55 muM. Angustidine (2), nauclefine (3), Angustine (4), angustoline (6) and harmane (7) showed higher BChE inhibiting potency compared to galanthamine. Angustidine (2) was the most potent inhibitor towards both AChE and BChE. Molecular docking (MD) studies showed that angustidine (2) docked deep into the bottom gorge of hBChE and formed hydrogen bonding with Ser 198 and His 438. Kinetic study of angustidine (2) on BChE suggested a mixed inhibition mode with an inhibition constant (Ki) of 6.12 muM.
Indole alkaloids of Psychotria as multifunctional cholinesterases and monoamine oxidases inhibitors.[Pubmed:23261030]
Phytochemistry. 2013 Feb;86:8-20.
Thirteen Psychotria alkaloids were evaluated regarding their interactions with acetylcholinesterase (AChE), butyrylcholinesterase (BChE), and monoamine oxidases A and B (MAO-A and MAO-B), which are enzymatic targets related with neurodegenerative diseases. Two quaternary beta-carboline alkaloids, prunifoleine and 14-oxoprunifoleine, inhibited AChE, BChE and MAO-A with IC(50) values corresponding to 10 and 3.39 muM for AChE, 100 and 11 muM for BChE, and 7.41 and 6.92 muM for MAO-A, respectively. Both compounds seem to behave as noncompetitive AChE inhibitors and time-dependent MAO-A inhibitors. In addition, the monoterpene indole alkaloids (MIAs) Angustine, vallesiachotamine lactone, E-vallesiachotamine and Z-vallesiachotamine inhibited BChE and MAO-A with IC(50) values ranging from 3.47 to 14 muM for BChE inhibition and from 0.85 to 2.14 muM for MAO-A inhibition. Among the tested MIAs, Angustine is able to inhibit MAO-A in a reversible and competitive way while the three vallesiachotamine-like alkaloids display a time-dependent inhibition on this target. Docking calculations were performed in order to understand the binding mode between the most active ligands and the selected targets. Taken together, our findings established molecular details of AChE, BChE and MAO-A inhibition by quaternary beta-carboline alkaloids and MIAs from Psychotria, suggesting these secondary metabolites are scaffolds for the development of multifunctional compounds against neurodegeneration.
Naucline, a new indole alkaloid from the bark of Nauclea officinalis.[Pubmed:22469596]
Molecules. 2012 Apr 2;17(4):4028-36.
A new indole alkaloid, naucline (1) together with four known alkaloids, Angustine (2), angustidine (3), nauclefine (4) and naucletine (5), were isolated from the bark of Nauclea officinalis. The structures of all isolated compounds were elucidated with various spectroscopic methods such as 1D- and 2D- NMR, IR, UV and LCMS-IT-TOF. In addition to that of alkaloid 1, the complete 13C-NMR data of naucletine (5) were also reported. Naucline (1) showed a moderate vasorelaxant activity (90% relaxation at 1 x 10(-5) M) whereas, Angustine (2), nauclefine (4), and naucletine (5) showed potent vasorelaxant activity (more than 90% relaxation at 1 x 10(-5) M) on an isolated rat aorta.
[Alkaloids from the leaves of Nauclea officinalis].[Pubmed:20939184]
Yao Xue Xue Bao. 2010 Jun;45(6):747-51.
To study chemical constituents of the leaves of Nauclea officinalis, eight alkaloids were isolated from 95% ethanol extract by various chromatographic methods. The structures were elucidated on the basis of spectroscopic data (IR, UV, ESI-MS, 1D and 2D NMR) and identified as naucleactonin C (1), strictosamide (2), vincosamide (3), pumiloside (4), angustoline (5), Angustine (6), 18, 19-dihydroAngustine (7) and naucleofficine D (8). Compound 1 is a new indole alkaloid. Compounds 6 and 7 were isolated from this plant for the first time.
Novel bis(monoterpenoid) indole alkaloids from Psychotria bahiensis.[Pubmed:12828456]
J Nat Prod. 2003 Jun;66(6):752-4.
Two new bis(monoterpenoid) indole alkaloid glucosides, bahienoside A (1) and bahienoside B (2), together with five known compounds, 5alpha-carboxystrictosidine, Angustine, strictosamide, and (E)- and (Z)-vallesiachotamine, were isolated from the aerial parts of Psychotria bahiensis collected in Trinidad, West Indies. The structures of the compounds were elucidated using 1D and 2D NMR spectral methods, viz., (1)H, (13)C, (13)C DEPT, (1)H-(1)H COSY, HSQC, HMQC, HMBC, and TOCSY aided by IR, UV, and circular dichroism measurements.
New indole alkaloids from Sarcocephalus latifolius.[Pubmed:11547422]
Nat Prod Lett. 2001;15(1):43-8.
Phytochemical investigation of the root extract of Sarcocephalus latifolius has led to the isolation of the new indole alkaloids 21-O-methylstrictosamide aglycone and 21-O-ethylstrictosamide aglycone, together with strictosamide, Angustine, nauclefine, angustidine, angustoline, 19-O-ethylangustoline, naucleidinal, 19-epi-naucleidinal, quinovic acid-3 beta-O-beta-D-fucopyranoside, quinovic acid-3 beta-O-alpha-L-rhamnopyranoside, scopoletin, and beta-sitosterol. Strictosamide displayed moderate antiplasmodial activity against Plasmodium falciparum.
Indole alkaloids with in vitro antiproliferative activity from the ammoniacal extract of Nauclea orientalis.[Pubmed:1620742]
Planta Med. 1992 Feb;58(1):43-8.
Nine Angustine-type alkaloids were isolated from ammoniacal extracts of Nauclea orientalis L. (Rubiaceae). Three of them, 10-hydroxyAngustine and the two diastereoisomeric 3,14-dihydroangustolines, have not been described in the literature thus far. The structures of the isolates were determined with spectroscopic methods, mainly 1D- and 2D-NMR spectroscopy. The compounds were found to exhibit in vitro anti-proliferative activity against the human bladder carcinoma T-24 cell line and against EGF (epidermal growth factor)-dependent mouse epidermal keratinocytes. By using overpressure layer chromatography, it was shown that minor quantities of these alkaloids occur in dried Nauclea orientalis leaves. The use of ammonia in the extraction process results in a significant increase in the formation of Angustine-type alkaloids from strictosamide-type precursors.
South American Strychnos species. Ethnobotany (except curare) and alkaloid screening.[Pubmed:2179633]
J Ethnopharmacol. 1990 Feb;28(1):1-52.
The ethnobotanical uses of South American species of Strychnos L. (Loganiaceae) are reviewed, with the exception of their major role in the preparation of curare, which will be dealt with in detail elsewhere. Medicinal uses are less common than is the case with the African and Asian species of the genus. About 140 samples, mostly of leaves, belonging to 53 species, have been screened for alkaloids. As with species from other parts of the world, the stem bark and root bark tend to be a richer source than leaves. Nor-harman is present in extracts from S. barnhartiana leaves. Pyridino-indolo-quinolizidinone (Angustine-type) bases are also found in several species. The occurrence and pharmacology of the (non-curarizing) alkaloids known to be present in South American Strychnos species is reviewed.